BOSTON - August 1, 2007 - In an effort to find a better therapy and improve the lives of people with epilepsy, the Massachusetts General Hospital (MGH) Epilepsy Service is participating in the RNS™ System Pivotal Clinical Investigation, a study to evaluate the safety and effectiveness of a responsive brain stimulation device in reducing the frequency of uncontrolled seizures. MGH is one of only 28 centers across the country participating in this study.
